1. Home
  2. ZLAB vs MCY Comparison

ZLAB vs MCY Comparison

Compare ZLAB & MCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • MCY
  • Stock Information
  • Founded
  • ZLAB 2013
  • MCY 1961
  • Country
  • ZLAB China
  • MCY United States
  • Employees
  • ZLAB N/A
  • MCY N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • MCY Property-Casualty Insurers
  • Sector
  • ZLAB Health Care
  • MCY Finance
  • Exchange
  • ZLAB Nasdaq
  • MCY Nasdaq
  • Market Cap
  • ZLAB 3.6B
  • MCY 3.1B
  • IPO Year
  • ZLAB 2017
  • MCY N/A
  • Fundamental
  • Price
  • ZLAB $32.54
  • MCY $66.10
  • Analyst Decision
  • ZLAB Buy
  • MCY Strong Buy
  • Analyst Count
  • ZLAB 5
  • MCY 1
  • Target Price
  • ZLAB $54.28
  • MCY $80.00
  • AVG Volume (30 Days)
  • ZLAB 782.4K
  • MCY 272.8K
  • Earning Date
  • ZLAB 08-05-2025
  • MCY 07-29-2025
  • Dividend Yield
  • ZLAB N/A
  • MCY 1.92%
  • EPS Growth
  • ZLAB N/A
  • MCY 32.82
  • EPS
  • ZLAB N/A
  • MCY 5.16
  • Revenue
  • ZLAB $418,326,000.00
  • MCY $5,595,427,000.00
  • Revenue This Year
  • ZLAB $44.07
  • MCY $7.13
  • Revenue Next Year
  • ZLAB $49.13
  • MCY $7.60
  • P/E Ratio
  • ZLAB N/A
  • MCY $12.80
  • Revenue Growth
  • ZLAB 43.72
  • MCY 16.64
  • 52 Week Low
  • ZLAB $16.01
  • MCY $44.19
  • 52 Week High
  • ZLAB $44.34
  • MCY $80.72
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 40.19
  • MCY 55.67
  • Support Level
  • ZLAB $34.26
  • MCY $64.21
  • Resistance Level
  • ZLAB $35.72
  • MCY $67.41
  • Average True Range (ATR)
  • ZLAB 1.12
  • MCY 1.49
  • MACD
  • ZLAB -0.54
  • MCY -0.17
  • Stochastic Oscillator
  • ZLAB 3.83
  • MCY 60.08

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About MCY Mercury General Corporation

Mercury General Corp is an insurance holding company. It is engaged in writing personal automobile insurance and provides related property and casualty insurance products. The Company offers the following types of automobile coverage: collision, property damage, bodily injury ("BI"), comprehensive, personal injury protection ("PIP"), underinsured and uninsured motorist, and other hazards. The Company offers the following types of homeowners coverage: dwelling, liability, personal property, and other coverages.

Share on Social Networks: